Pfizer Ventures

Pfizer Ventures: Investing in Science. Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. We actively support our current portfolio companies throughout their growth cycles contributing strategic guidance in addition to capital as well as access to Pfizer expertise, when appropriate. With a $900M capital commitment for investment, Pfizer Ventures backs private companies at all stages of development. We have a strong focus on early-stage opportunities. But other investments, including start-ups and spinouts, are also considered in scope. While primarily U.S.-focused, international investments may represent up to 20 percent of the portfolio.